Get the Stockscreener App
3.07
6.23%
0.18
Biote Corp stock is traded at $3.07, with a volume of 226.41K.
It is up +6.23% in the last 24 hours and down -24.75% over the past month.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
See More
Previous Close:
$2.89
Open:
$2.95
24h Volume:
226.41K
Relative Volume:
1.57
Market Cap:
$101.53M
Revenue:
$185.36M
Net Income/Loss:
$3.32M
P/E Ratio:
-38.38
EPS:
-0.08
Net Cash Flow:
$24.17M
1W Performance:
-20.47%
1M Performance:
-24.75%
6M Performance:
-32.97%
1Y Performance:
-46.42%
1-Day Range:
$2.91
$3.1795
1-Week Range:
$2.76
$3.22
52-Week Range:
$2.76
$6.98
Biote Corp Stock (BTMD) Company Profile
Name
Biote Corp
Sector
Industry
Phone
972-486-9346
Address
1875 W. WALNUT HILL LN #100, IRVING
Compare BTMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BTMD
Biote Corp. Class A Common Stock
|
5.89 | 33.33M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.90 | 1.23B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.38 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.60 | 112.82M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1534 | 324.91M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.4425 | 0 | 0 | 0 | 0 | 0.00 |
Biote Corp Stock (BTMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Dec-16-24 | Initiated | Craig Hallum | Buy |
| Feb-20-24 | Initiated | B. Riley Securities | Buy |
| Feb-01-24 | Initiated | Jefferies | Buy |
| Jun-24-22 | Initiated | Cowen | Outperform |
| Jun-23-22 | Initiated | ROTH Capital | Buy |
View All
Biote Corp Stock (BTMD) Latest News
Applying sector rotation models to biote Corp.Quarterly Market Review & Weekly Top Gainers Trade List - Newser
What institutional flow reveals about biote Corp.Market Performance Summary & Technical Confirmation Trade Alerts - Newser
Visual trend scoring systems applied to biote Corp.Strategy Playbook for Risk Controlled Trades - Newser
Biote Corp.'s Q2 2025 Earnings Call: Navigating Contradictions in Verticalization, Volume Declines, and Revenue Growth Expectations - AInvest
Can trapped investors hope for a rebound in biote Corp.Buy Strategy Tracker with Growth Indicators - Newser
B. Riley Has Pessimistic Outlook of biote FY2025 Earnings - Defense World
Intraday pattern recognizer results for biote Corp.AI Trend Detection for Entry Timing - Newser
Biote Corp. Reports Strong Q2 2025 Financial Results - TipRanks
Biote outlines revenue above $190M for 2025 amid organizational restructuring and sales force overhaul - MSN
What makes biote Corp. stock price move sharplyShort-Term Upside Breakout Forecast System - Newser
biote (NASDAQ:BTMD) Cut to Neutral at B. Riley - Defense World
What risks could impact biote Corp. stock performanceDaily Profit Watch With Forecast Confidence - Newser
Is biote Corp. Starting a New UptrendLong Term Investment Summary Prediction - beatles.ru
How does biote Corp. correlate with NasdaqInsider Buys Signal Tracker - thegnnews.com
Results: biote Corp. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
biote (NASDAQ:BTMD) Lowered to Hold Rating by Wall Street Zen - Defense World
Biote Corp. Earnings Call: Growth Amid Challenges - The Globe and Mail
biote Corp. SEC 10-Q Report - TradingView
A Quick Look at Today's Ratings for Biote(BTMD.US), With a Forecast Between $4 to $6 - 富途牛牛
Biote Corp. shares fall 1.03% intraday after Q2 earnings call. - AInvest
Little Excitement Around Biote Corp.'s (NASDAQ:BTMD) Earnings As Shares Take 28% Pounding - 富途牛牛
biote Corp. (NASDAQ:BTMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Benign Growth For biote Corp. (NASDAQ:BTMD) Underpins Stock's 28% Plummet - simplywall.st
How to use a screener to detect biote Corp. breakoutsReal-Time Entry Forecast with Accuracy Metrics - Newser
B. Riley Securities Downgrades Biote to Neutral from Buy, PT $4 - AInvest
biote stock price target lowered to $5 from $6 at Roth/MKM - Investing.com Nigeria
Biote downgraded to Neutral from Buy at B. Riley - TipRanks
Truist Cuts Price Target on biote to $6 From $7, Keeps Buy Rating - MarketScreener
biote stock price target lowered to $5.92 from $6.99 at Jefferies - Investing.com India
Earnings call transcript: Biote Corp beats EPS expectations in Q2 2025 - Investing.com India
Biote Reports Q2 EPS 10c, Revenue $48.9M, Beats Estimate - AInvest
Biote Corp. (BTMD) Q2 2025 Earnings and Growth Trajectory: Scaling a Differentiated Medical Franchise in the Hormone Optimization Market - AInvest
Biote Misses Revenue Target But Dietary Supplements Shine - Finimize
Biote Bets Big On Supplements As Procedure Revenue Slips - Finimize
Biote Corp reports results for the quarter ended June 30Earnings Summary - TradingView
How to read the order book for biote Corp.Free Step-by-Step Stock Investment Guide - Newser
Why biote Corp. stock attracts strong analyst attentionFree Buy Low Sell High Stock Watch - Newser
biote Corp. (BTMD) Tops Q2 Earnings Estimates - Yahoo Finance
Healthcare firm Biote Q2 revenue misses expectations - MarketScreener
Biote Corp. shares fall 13.21% after-hours as Novartis considers Avidity Biosciences acquisition. - AInvest
biote Corp earnings beat by $0.02, revenue fell short of estimates - Investing.com Canada
Biote Corp Stock (BTMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biote Corp Stock (BTMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Guines LLC | 10% Owner |
May 07 '25 |
Buy |
3.35 |
11,677 |
39,107 |
4,622,748 |
| Guines LLC | 10% Owner |
Apr 30 '25 |
Buy |
3.30 |
1,933 |
6,371 |
4,175,034 |
| Guines LLC | 10% Owner |
Apr 21 '25 |
Buy |
3.27 |
8,801 |
28,782 |
4,173,101 |
| Guines LLC | 10% Owner |
Apr 17 '25 |
Buy |
3.29 |
6,874 |
22,615 |
4,164,300 |
| Guines LLC | 10% Owner |
Apr 16 '25 |
Buy |
3.29 |
1,000 |
3,292 |
4,157,426 |
| Guines LLC | 10% Owner |
Apr 08 '25 |
Buy |
3.21 |
34,907 |
111,985 |
4,142,894 |
| Guines LLC | 10% Owner |
Apr 09 '25 |
Buy |
3.21 |
13,532 |
43,403 |
4,156,426 |
| Guines LLC | 10% Owner |
Apr 07 '25 |
Buy |
3.15 |
43,378 |
136,706 |
4,107,987 |
| Guines LLC | 10% Owner |
Apr 04 '25 |
Buy |
3.24 |
23,741 |
76,954 |
4,064,609 |
| Guines LLC | 10% Owner |
Apr 03 '25 |
Buy |
3.24 |
7,321 |
23,746 |
4,040,868 |
0.03%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):